{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:31:00Z","timestamp":1785879060439,"version":"3.56.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF11OC1014514"],"award-info":[{"award-number":["NNF11OC1014514"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"crossref","award":["E-22463-02"],"award-info":[{"award-number":["E-22463-02"]}],"id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12311-019-01092-8","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T12:34:21Z","timestamp":1577968461000},"page":"165-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Enhancement of Autophagy and Solubilization of Ataxin-2 Alleviate Apoptosis in Spinocerebellar Ataxia Type 2 Patient Cells"],"prefix":"10.1007","volume":"19","author":[{"given":"Jonathan Henry","family":"Wardman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil Elb\u00e6k","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele Gabriele","family":"Marthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Erik","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels Tolstrup","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"1092_CR1","doi-asserted-by":"crossref","unstructured":"Takeuchi T, Nagai Y. Protein misfolding and aggregation as a therapeutic target for polyglutamine diseases. Brain Sci. 2017;7 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29019918. Accessed 30 Sep 2019.","DOI":"10.3390\/brainsci7100128"},{"key":"1092_CR2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","volume":"421","author":"I S\u00e1nchez","year":"2003","unstructured":"S\u00e1nchez I, Mahlke C, Yuan J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature. 2003;421:373\u20139.","journal-title":"Nature."},{"key":"1092_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","volume":"9","author":"A Durr","year":"2010","unstructured":"Durr A. Autosomal dominant cerebellar ataxias: Polyglutamine expansions and beyond. Lancet Neurol. 2010;9:885\u201394. https:\/\/doi.org\/10.1016\/S1474-4422(10)70183-6.","journal-title":"Lancet Neurol"},{"key":"1092_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10059-013-0167-x","volume":"36","author":"TW Todd","year":"2013","unstructured":"Todd TW, Lim J. Aggregation formation in the polyglutamine diseases: protection at a cost? Mol Cells. 2013;36:185\u201394 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23794019. Accessed 30 Sep 2019.","journal-title":"Mol Cells"},{"key":"1092_CR5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004;36:585\u201395.","journal-title":"Nat Genet"},{"key":"1092_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-59745-157-4_13","volume":"445","author":"B Ravikumar","year":"2008","unstructured":"Ravikumar B, Sarkar S, Rubinsztein DC. Clearance of mutant aggregate-prone proteins by autophagy. Methods Mol Biol Humana Press. 2008;445:195\u2013211.","journal-title":"Methods Mol Biol Humana Press"},{"key":"1092_CR7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4161\/auto.6259","volume":"4","author":"RA Nixon","year":"2008","unstructured":"Nixon RA, Yang D-S, Lee J-H. Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy. 2008;4:590\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18497567. Accessed 11 Aug 2015.","journal-title":"Autophagy"},{"key":"1092_CR8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19:983\u201397 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23921753. Accessed 30 Sep 2019.","journal-title":"Nat Med"},{"key":"1092_CR9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1196\/annals.1427.015","volume":"1147","author":"AA Starkov","year":"2008","unstructured":"Starkov AA. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann N Y Acad Sci. 2008;1147:37\u201352 Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2869479&tool=pmcentrez&rendertype=abstract. Accessed 9 Apr 2015.","journal-title":"Ann N Y Acad Sci"},{"key":"1092_CR10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nn.2575","volume":"13","author":"E Wong","year":"2010","unstructured":"Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci. 2010;13:805\u201311 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20581817. Accessed 30 Sep 2019.","journal-title":"Nat Neurosci"},{"issue":"11","key":"1092_CR11","doi-asserted-by":"crossref","first-page":"26797","DOI":"10.3390\/ijms161125990","volume":"16","author":"Yoshimitsu Kiriyama","year":"2015","unstructured":"Kiriyama Y, Nochi H. The function of autophagy in neurodegenerative diseases. Int J Mol Sci, 16. 2015:26797\u2013812 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26569220. Accessed 30 Sep 2019.","journal-title":"International Journal of Molecular Sciences"},{"key":"1092_CR12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.112.192138","volume":"342","author":"A Johri","year":"2012","unstructured":"Johri A, Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther. 2012;342:619\u201330 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22700435. Accessed 30 Sep 2019.","journal-title":"J Pharmacol Exp Ther"},{"key":"1092_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mito.2017.03.001","volume":"34","author":"Nanna Cornelius","year":"2017","unstructured":"Cornelius N, Wardman JH, Hargreaves IP, Neergheen V, Bie AS, T\u00fcmer Z, et al. Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: effect of coenzyme Q10 supplementation on these parameters. Mitochondrion. 2017;34.","journal-title":"Mitochondrion"},{"key":"1092_CR14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/ars.2013.5746","volume":"21","author":"VO Kaminskyy","year":"2014","unstructured":"Kaminskyy VO, Zhivotovsky B. Free radicals in cross talk between autophagy and apoptosis. Antioxid Redox Signal. 2014;21:86\u2013102 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24359220. Accessed 6 Jul 2015.","journal-title":"Antioxid Redox Signal"},{"issue":"1-2","key":"1092_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jns.2012.05.030","volume":"322","author":"Antonio Federico","year":"2012","unstructured":"Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci. Elsevier B.V.; 2012;322:254\u201362. Available from: https:\/\/doi.org\/10.1016\/j.jns.2012.05.030. Accessed 6 Jul 2015","journal-title":"Journal of the Neurological Sciences"},{"key":"1092_CR16","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1093\/emboj\/cdg634","volume":"22","author":"H Inoue","year":"2003","unstructured":"Inoue H, Tsukita K, Iwasato T, Suzuki Y, Tomioka M, Tateno M, et al. The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model. EMBO J. 2003;22:6665\u201374 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14657037.","journal-title":"EMBO J"},{"key":"1092_CR17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/35040009","volume":"1","author":"MP Mattson","year":"2000","unstructured":"Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol. 2000;1:120\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11253364.. Accessed 30 Sep 2019.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1092_CR18","doi-asserted-by":"crossref","first-page":"e0121089","DOI":"10.1371\/journal.pone.0121089","volume":"10","author":"MV Halbach","year":"2015","unstructured":"Halbach MV, Stehning T, Damrath E, Jendrach M, \u015een NE, Ba\u015fak AN, et al. Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated. PLoS One. 2015;10:e0121089 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25790475. Accessed 30 Sep 2019.","journal-title":"PLoS One"},{"key":"1092_CR19","doi-asserted-by":"crossref","unstructured":"Paul S, Dansithong W, Figueroa KP, Scoles DR, Pulst SM. Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration. Nat Commun. 2018;9.","DOI":"10.1038\/s41467-018-06041-3"},{"key":"1092_CR20","unstructured":"Bird TD. Hereditary ataxia overview. GeneReviews. 2015."},{"key":"1092_CR21","doi-asserted-by":"crossref","unstructured":"David DC. Aging and the aggregating proteome. Front Genet. 2012.","DOI":"10.3389\/fgene.2012.00247"},{"key":"1092_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10048-015-0441-5","volume":"16","author":"M Fittschen","year":"2015","unstructured":"Fittschen M, Lastres-Becker I, Halbach MV, Damrath E, Gispert S, Azizov M, et al. Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate. Neurogenetics. 2015;16:181\u201392.","journal-title":"Neurogenetics"},{"key":"1092_CR23","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbadis.2016.05.017","volume":"1862","author":"I Lastres-Becker","year":"2016","unstructured":"Lastres-Becker I, Nonis D, Eich F, Klinkenberg M, Gorospe M, K\u00f6tter P, et al. Mammalian ataxin-2 modulates translation control at the pre-initiation complex via PI3K\/mTOR and is induced by starvation. Biochim Biophys Acta. 2016;1862:1558\u201369 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27240544. Accessed 30 Sep 2019.","journal-title":"Biochim Biophys Acta"},{"issue":"16","key":"1092_CR24","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/hmg\/ddl173","volume":"15","author":"Terrence F. Satterfield","year":"2006","unstructured":"Satterfield TF, Pallanck LJ. Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes. Hum.Mol.Genet. 2006:2523\u201332.","journal-title":"Human Molecular Genetics"},{"key":"1092_CR25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s12311-010-0182-9","volume":"11","author":"A Kasumu","year":"2012","unstructured":"Kasumu A, Bezprozvanny I. Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias. Cerebellum. 2012;11:630\u20139 Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3257360&tool=pmcentrez&rendertype=abstract. Acessed 9 Apr 2015.","journal-title":"Cerebellum"},{"key":"1092_CR26","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1523\/JNEUROSCI.0660-09.2009","volume":"29","author":"J Liu","year":"2009","unstructured":"Liu J, Tang TS, Tu H, Nelson O, Herndon E, Huynh DP, et al. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J Neurosci. 2009;29:9148\u201362.","journal-title":"J Neurosci"},{"key":"1092_CR27","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1091\/mbc.e06-12-1120","volume":"18","author":"U Nonhoff","year":"2007","unstructured":"Nonhoff U, Ralser M, Welzel F, Piccini I, Balzereit D, Yaspo M-L, et al. Ataxin-2 interacts with the DEAD\/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol Biol Cell. 2007;18:1385\u201396 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17392519. Accessed 30 Sep 2019.","journal-title":"Mol Biol Cell"},{"key":"1092_CR28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature14859","volume":"524","author":"X Wang","year":"2015","unstructured":"Wang X, Chen XJ. A cytosolic network suppressing mitochondria-mediated proteostatic stress and cell death. Nature. 2015;524:481\u20134.","journal-title":"Nature"},{"key":"1092_CR29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/acs.jproteome.6b00647","volume":"16","author":"G Seidel","year":"2017","unstructured":"Seidel G, Meierhofer D, \u015een NE, Guenther A, Krobitsch S, Auburger G. Quantitative global proteomics of yeast PBP1 deletion mutants and their stress responses identifies glucose metabolism, mitochondrial, and stress granule changes. J Proteome Res. 2017;16:504\u201315.","journal-title":"J Proteome Res"},{"key":"1092_CR30","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1074\/mcp.M115.056770","volume":"15","author":"D Meierhofer","year":"2016","unstructured":"Meierhofer D, Halbach M, \u015een NE, Gispert S, Auburger G. Ataxin-2 (Atxn2)-knock-out mice show branched chain amino acids and fatty acids pathway alterations. Mol Cell Proteomics. 2016;15:1728\u201339 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26850065. Accessed 30 Sep 2019.","journal-title":"Mol Cell Proteomics"},{"key":"1092_CR31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.cell.2019.02.044","volume":"177","author":"M Kato","year":"2019","unstructured":"Kato M, Yang Y-S, Sutter BM, Wang Y, McKnight SL, Tu BP. Redox state controls phase separation of the yeast ataxin-2 protein via reversible oxidation of its methionine-rich low-complexity domain. Cell. 2019;177:711\u2013721.e8 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30982603. Accessed 4 Oct 2019.","journal-title":"Cell"},{"issue":"1","key":"1092_CR32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"Harry T. Orr","year":"2007","unstructured":"Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 2007:575\u2013621.","journal-title":"Annual Review of Neuroscience"},{"issue":"3","key":"1092_CR33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng1196-285","volume":"14","author":"Georges Imbert","year":"1996","unstructured":"Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, Garnier JM, et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG\/glutamine repeats. Nat Genet. 1996:285\u201391.","journal-title":"Nature Genetics"},{"issue":"3","key":"1092_CR34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng1196-269","volume":"14","author":"Stefan-M. Pulst","year":"1996","unstructured":"Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, Lopes-Cendes I, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996:269\u201376.","journal-title":"Nature Genetics"},{"key":"1092_CR35","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/hmg\/ddn035","volume":"17","author":"I Lastres-Becker","year":"2008","unstructured":"Lastres-Becker I, Brodesser S, L\u00fctjohann D, Azizov M, Buchmann J, Hintermann E, et al. Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Hum Mol Genet. 2008;17:1465\u201381 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18250099. Accessed 30 Sep 2019.","journal-title":"Hum Mol Genet"},{"key":"1092_CR36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/07420528.2016.1245666","volume":"34","author":"M Pfeffer","year":"2017","unstructured":"Pfeffer M, Gispert S, Auburger G, Wicht H, Korf H-W. Impact of Ataxin-2 knock out on circadian locomotor behavior and PER immunoreaction in the SCN of mice. Chronobiol Int. 2017;34:129\u201337 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27791392. Accessed 30 Sep 2019.","journal-title":"Chronobiol Int"},{"key":"1092_CR37","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000275","volume":"4","author":"SL Gardiner","year":"2018","unstructured":"Gardiner SL, Milanese C, Boogaard MW, Buijsen RAM, Hogenboom M, Roos RAC, et al. Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset. Neurol Genet. 2018;4:e275 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30338295. Accessed 30 Sep 2019.","journal-title":"Neurol Genet"},{"issue":"2","key":"1092_CR38","doi-asserted-by":"crossref","first-page":"e90202","DOI":"10.1371\/journal.pone.0090202","volume":"9","author":"Maria Angeles Fernandez-Estevez","year":"2014","unstructured":"Fernandez-Estevez MA, Casarejos MJ, Sendon JL, Caldentey JG, Ruiz C, Gomez A, et al. Trehalose reverses cell malfunction in fibroblasts from normal and Huntington\u2019s disease patients caused by proteosome inhibition. PLoS One. 2014;9.","journal-title":"PLoS ONE"},{"issue":"11","key":"1092_CR39","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T. Schmitz-Hubsch","year":"2006","unstructured":"Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006:1717\u201320.","journal-title":"Neurology"},{"key":"1092_CR40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2012.07.036","volume":"321","author":"TT Nielsen","year":"2012","unstructured":"Nielsen TT, Svenstrup K, Budtz-J\u00f8rgensen E, Eiberg H, Hasholt L, Nielsen JE. ATXN2 with intermediate-length CAG\/CAA repeats does not seem to be a risk factor in hereditary spastic paraplegia. J Neurol Sci. 2012;321:100\u20132.","journal-title":"J Neurol Sci"},{"issue":"13","key":"1092_CR41","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/hmg\/ddg175","volume":"12","author":"D. P. Huynh","year":"2003","unstructured":"Huynh DP, Yang HT, Vakharia H, Nguyen D, Pulst SM. Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death. Hum Mol Genet. 2003:1485\u201396.","journal-title":"Human Molecular Genetics"},{"key":"1092_CR42","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1523\/JNEUROSCI.0996-12.2012","volume":"32","author":"MP Hart","year":"2012","unstructured":"Hart MP, Gitler AD. ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications. J Neurosci. 2012;32:9133\u201342 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22764223. Accessed 1 Oct 2019.","journal-title":"J Neurosci"},{"key":"1092_CR43","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1073\/pnas.96.10.5752","volume":"96","author":"S Krajewski","year":"1999","unstructured":"Krajewski S, Krajewska M, Ellerby LM, Welsh K, Xie Z, Deveraux QL, et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci U S A. 1999;96:5752\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1092_CR44","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","volume":"281","author":"DR Green","year":"1998","unstructured":"Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309\u201312.","journal-title":"Science"},{"key":"1092_CR45","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/cdd.2011.27","volume":"18","author":"MA Laussmann","year":"2011","unstructured":"Laussmann MA, Passante E, D\u00fcssmann H, Rauen JA, W\u00fcrstle ML, Delgado ME, et al. Proteasome inhibition can induce an autophagy-dependent apical activation of caspase-8. Cell Death Differ. 2011;18:1584\u201397.","journal-title":"Cell Death Differ"},{"key":"1092_CR46","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1128\/MCB.05460-11","volume":"31","author":"J-A Pan","year":"2011","unstructured":"Pan J-A, Ullman E, Dou Z, Zong W-X. Inhibition of protein degradation induces apoptosis through a microtubule-associated protein 1 light chain 3-mediated activation of caspase-8 at intracellular membranes. Mol Cell Biol. 2011;31:3158\u201370.","journal-title":"Mol Cell Biol."},{"key":"1092_CR47","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jns.2016.11.075","volume":"372","author":"LE Almaguer-Mederos","year":"2017","unstructured":"Almaguer-Mederos LE, Almaguer-Gotay D, Aguilera-Rodr\u00edguez R, Gonz\u00e1lez-Zald\u00edvar Y, Cuello-Almarales D, Laffita-Mesa J, et al. Association of glutathione S-transferase omega polymorphism and spinocerebellar ataxia type 2. J Neurol Sci. 2017;372:324\u20138.","journal-title":"J Neurol Sci."},{"key":"1092_CR48","doi-asserted-by":"crossref","first-page":"22426","DOI":"10.1074\/jbc.M110.149252","volume":"286","author":"N Myeku","year":"2011","unstructured":"Myeku N, Figueiredo-Pereira ME. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1\/p62. J Biol Chem. 2011;286:22426\u201340.","journal-title":"J Biol Chem"},{"key":"1092_CR49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.redox.2016.11.004","volume":"11","author":"M Redmann","year":"2017","unstructured":"Redmann M, Benavides GA, Berryhill TF, Wani WY, Ouyang X, Johnson MS, et al. Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial quality and bioenergetic function in primary neurons. Redox Biol. 2017;11:73\u201381.","journal-title":"Redox Biol."},{"key":"1092_CR50","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cell.2019.02.043","volume":"177","author":"YS Yang","year":"2019","unstructured":"Yang YS, Kato M, Wu X, Litsios A, Sutter BM, Wang Y, et al. Yeast ataxin-2 forms an intracellular condensate required for the inhibition of TORC1 signaling during respiratory growth. Cell. 2019;177:697\u2013710.e17.","journal-title":"Cell"},{"key":"1092_CR51","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1091\/mbc.E14-06-1088","volume":"26","author":"D DeMille","year":"2015","unstructured":"DeMille D, Badal BD, Evans JB, Mathis AD, Anderson JF, Grose JH. PAS kinase is activated by direct SNF1-dependent phosphorylation and mediates inhibition of TORC1 through the phosphorylation and activation of Pbp1. Mol Biol Cell. 2015;26:569\u201382.","journal-title":"Mol Biol Cell."},{"key":"1092_CR52","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4161\/auto.4898","volume":"3","author":"RA Floto","year":"2007","unstructured":"Floto RA, Sarkar S, Perlstein EO, Kampmann B, Schreiber SL, Rubinsztein DC. Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington\u2019s disease models and enhance killing of mycobacteria by macrophages. Autophagy. 2007;3:620\u20132 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17786022. Accessed 1 Oct 2019.","journal-title":"Autophagy"},{"key":"1092_CR53","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4161\/auto.27710","volume":"10","author":"X Zhang","year":"2014","unstructured":"Zhang X, Chen S, Song L, Tang Y, Shen Y, Jia L, et al. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy. 2014;10:588\u2013602.","journal-title":"Autophagy"},{"key":"1092_CR54","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1074\/jbc.M609532200","volume":"282","author":"S Sarkar","year":"2007","unstructured":"Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and \u03b1-synuclein. J Biol Chem. 2007;282:5641\u201352.","journal-title":"J Biol Chem"},{"issue":"1","key":"1092_CR55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cdd.2008.110","volume":"16","author":"S Sarkar","year":"2008","unstructured":"Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 2009:46\u201356.","journal-title":"Cell Death & Differentiation"},{"issue":"Suppl","key":"1092_CR56","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0140-6736(01)07048-9","volume":"358","author":"HT Orr","year":"2001","unstructured":"Orr HT. Hereditary ataxia. An unfolded protein. Lancet (London, England). 2001;358(Suppl):S35 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11784584. Accessed 1 Oct 2019.","journal-title":"Lancet (London, England)"},{"key":"1092_CR57","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1141448","volume":"319","author":"WE Balch","year":"2008","unstructured":"Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science. 2008;319:916\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18276881. Accessed 1 Oct 2019.","journal-title":"Science"},{"key":"1092_CR58","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1073\/pnas.0408936102","volume":"102","author":"X Zhang","year":"2005","unstructured":"Zhang X, Smith DL, Meriin AB, Engemann S, Russel DE, Roark M, et al. A potent small molecule inhibits polyglutamine aggregation in Huntington\u2019s disease neurons and suppresses neurodegeneration in vivo. Proc Natl Acad Sci U S A. 2005;102:892\u20137 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15642944. Accessed 2 Oct 2019.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1092_CR59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2006.08.001","volume":"53","author":"P Frid","year":"2007","unstructured":"Frid P, Anisimov SV, Popovic N. Congo red and protein aggregation in neurodegenerative diseases. Brain Res Rev. 2007;53:135\u201360 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16959325. Accessed 15 Oct 2019.","journal-title":"Brain Res Rev"},{"key":"1092_CR60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/79162","volume":"26","author":"S-M Pulst","year":"2000","unstructured":"Pulst S-M, Huynh DP, Figueroa K, Hoang N. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet. 2000;26:44\u201350 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10973246. Accessed 11 Feb 2017.","journal-title":"Nat Genet"},{"key":"1092_CR61","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.neuint.2011.01.008","volume":"58","author":"MJ Casarejos","year":"2011","unstructured":"Casarejos MJ, Solano RM, G\u00f3mez A, Perucho J, de Y\u00e9benes JG, Mena MA. The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells. Neurochem Int. 2011;58:512\u201320 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21232572. Accessed 1 Oct 2019.","journal-title":"Neurochem Int"},{"key":"1092_CR62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopha.2015.07.025","volume":"74","author":"AH Bhat","year":"2015","unstructured":"Bhat AH, Dar KB, Anees S, Zargar MA, Masood A, Sofi MA, et al. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 2015;74:101\u201310 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26349970. Accessed 1 Oct 2019.","journal-title":"Biomed Pharmacother"},{"key":"1092_CR63","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"C Soto","year":"2003","unstructured":"Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 2003;4:49\u201360 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12511861. Accessed 1 Oct 2019.","journal-title":"Nat Rev Neurosci"},{"key":"1092_CR64","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0959-4388(96)80100-0","volume":"6","author":"MF Beal","year":"1996","unstructured":"Beal MF. Mitochondria, free radicals, and neurodegeneration. Curr Opin Neurobiol. 1996;6:661\u20136 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8937831. Accessed 5 May 2015.","journal-title":"Curr Opin Neurobiol"},{"key":"1092_CR65","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1046\/j.1471-4159.2001.00302.x","volume":"77","author":"Q Ding","year":"2001","unstructured":"Ding Q, Keller JN. Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J Neurochem. 2001;77:1010\u20137 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11359866. Accessed 1 Oct 2019.","journal-title":"J Neurochem"},{"key":"1092_CR66","doi-asserted-by":"crossref","unstructured":"Bartolom\u00e9 A, Garc\u00eda-Aguilar A, Asahara S-I, Kido Y, Guill\u00e9n C, Pajvani UB, et al. MTORC1 regulates both general autophagy and mitophagy induction after oxidative phosphorylation uncoupling. Mol Cell Biol. 2017;37 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28894028. Accessed 1 Oct 2019.","DOI":"10.1128\/MCB.00441-17"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-019-01092-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12311-019-01092-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-019-01092-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T01:32:07Z","timestamp":1609464727000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12311-019-01092-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1007\/s12311-019-01092-8","relation":{},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"2 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}